IP Verse

Oligonucleotides For Inducing Paternal Ube3A Expression

Patent No. EP4220360 (titled "Oligonucleotides For Inducing Paternal Ube3A Expression") was filed by F Hoffmann LA Roche on Nov 11, 2016. The application was issued on Oct 16, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
IONIS PHARMACEUTICALSMar 26, 2025CARPMAELS & RANSFORD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4220360

F HOFFMANN LA ROCHE
Application Number
EP23152543A
Filing Date
Nov 11, 2016
Status
Granted And Under Opposition
May 24, 2024
Publication Date
Oct 16, 2024
External Links
Slate, Register , Google Patents